Patriot Scientific der Highflyer 2006

 

Aber ob dann damit alle zufrieden sind..??  

3 Cents runter in USA. Pohl läßt uns ganz schön warten.  

MUCH MUCH is going to happen over the next 9-weeks.

1) Several more new licensing sign-ups to the MMP Patent Portfolio

2) A 3rd dividend.

3) Announcement on Seiko system Licensing agreement details

4) Announcement on Pentax system Licensing agreement details

5) Announcement on SONY system Licensing agreement details

6) Announcement on Nikon system licensing agreement details

7)Awesome quarterly report with royalty payment revenue. Currently estimated at $75 million plus overall.

TPL/PTSC and alliacense are truly working in the best interests of the stock holders. Their negotiation duties right now are relentless. Alliacense is hiring more ambitious and conscientious employees.

And of course in the background it is still Intel Versus the STI boys.

ANLYST
 

 

Anlyst wird da nämlich nur noch der Clown genannt (manche sagen - etwas freundlicher - Mickey Mouse oder so).

Seine ganzen dollen Prognosen treten nämlich (leider) nie ein. 2004 prognostizierte er etwa schon Zahlungen über mehrere hundert Mios durch Intel. Was ist daraus geworden?

Jetzt kommt er alle 2-3 Monate mit einer angeblichen Übernahme (seiner letzten Prognose nach müsste es spätestens in den nächsten Wochen zu einer Übernahme durch Intel oder STI zu 12USD/Aktie kommen...).

Er behauptet selber immer, ca. 15 Mio PTSC-Aktien zu verwalten. Also entweder ist auch das Gelaber oder zumindest wird hierdurch der Grund seiner positiven Postings klar.

Naja, freuen würde es mich natürlich schon, wenn Anlyst mal Recht hätte mit seinen Prognosen...

 

wenns 12$ pro Aktie geben würde. Ich würd n schönes Fass aufmachen. :-)
Aber ansonsten wart ich auch gern einfach ab und schau mir demnächste erstma die Q2 zahlen an.  

What is Patriot Scientific's fiscal year?
Patriot Scientific's fiscal year begins June 1st and ends May 31st.

Q1 June 1 - August 31
Q2 September 1 - November 30
Q3 December 1 - February 29
Q4 March 1 - May 31

When does Patriot Scientific release earnings?
The company releases earnings 30 to 45 days following the end of the quarter and 60 to 90 days following the end of the year.

So, when to expect SEC filings?
EOY 60-90 days from May 31 = July 31 - August 31.
EOQ 30-45 days from August 31 = September 31 - October 15.

 

"We love to entertain you"

GL1800

 

 

 

 

 

Hier könnt euch ja schon mal die vergangenen Patriot SEC-Filings anguggen und studieren:

http://www.sec.gov/cgi-bin/...amp;owner=include&action=getcompany

 

"We love to entertain you"

GL1800

 

was ist los, bald wird was abgehen.

Wer weiß genau was Sache ist bzgl. der Bekanntgabe neuer Lizenznehmer ? In den Ami-Boards ist zu lesen, dass die einzelnen Vertragsabschlüsse immer noch schnellstmöglich (nach Absprache mit TPL) gemeldet werden, aber auch die Variante, dass diese nur noch in den Quartalsberichten auftauchen.

Abenteurer, bist Du in der Nähe oder irgendwo auf nem Biobauernhof :-) ??  

Wenn ich mir das W:O board anschaue, dann ist das hier (obwohl weniger gepostet wird)eine geradezu himmlische Ruhe und Gelassenheit.

Wer wirklich überzeugt ist,der hat auch die nötige Zeit und denkt nicht in Wochen und Monaten.

greetz joker  

WO-Board seh ich auch so, und gedulden müssen wir uns auch nicht mehr so lange :-).

Na ja joker, Du hast ja einen Zeitvertreib gefunden *fg*.  

vertreiben.*fg*

Man wird doch noch ein wenig spielen dürfen.*lol*  

gemopst.;-)))  

ist ja wirklich nix los - kann man auch nichts schreiben, wenn nichts passier.

Hallo Matze, nee mit dem Biobauernhof ist schon wieder vorbei, bin nur etwas schreibfaul im Moment.

Grüße Abenteurer  

 

in NY wird immer schwächer.Keiner will mehr rein und keiner verkauft zu diesem Kurs.
Alle warten auf die Zahlen und insbesondere auf den Ausblick.
Spätestens bis zum 31.8. muß was kommen, falls PTSC nicht die übliche Fristverlängerung beantragt.  

http://www.woodynorris.com/Articles/SanDiegoUnionTribune3.htm  

Subject: Holy Cow!
From theInformer
PostID 497081  On Friday, August 11, 2006 (EST) at 1:08:56 PM

--------------------------------------------------


IP-backed securitisation: realizing the potential


--------------------------------------------------

Nigel Jones and Ann Hoe
Linklaters

IP assets are increasingly being recognized as key business assets. Their management, including to fund business activities, is now said to be “a pillar of corporate strategy”. In addition, there is an increasing desire on the part of most IP owners to turn them from being a cost to a profit centre.

Figures quoted to support this thesis are impressive. Ninety per cent of worldwide corporate net worth can be attributed to intangibles and intellectual property. The total asset value of patents alone is about US$1 trillion, with the value of total global intellectual property estimated to be between US$4 trillion and US$7 trillion. IP licensing revenue worldwide is expected to exceed US$500 million (compared with an estimated US$18 million for 1990) - IBM alone receives between US$1.5 billion and US$2 billion in annual licensing revenue. In addition, recent changes in accounting standards mean that increasingly companies have to carry out regular valuations of their IP assets, which obviously increases their visibility. Therefore, there is clearly no lack of encouragement for companies and their financial advisers to use these key assets in their financing.

Securitisation and its benefits

Securitisation is one way in which the originator (usually a company, but in some cases an individual) can raise finance. Securitisation can be defined as “a device of structuring financing where an entity seeks to pool together its interests in identifiable cashflows over time, transfer the same to investors either with or without the support of further collateral, and thereby achieve the purpose of financing”.

Therefore, a fundamental requirement is that there be an asset or asset pool that generates a cashflow, and ideally a regular and predictable cashflow. It is this cashflow that forms the basis of the securitisation loan or the asset-backed security (ABS). Essentially the originator sells a stream of cashflows that would otherwise accrue to it. Typically, and put simply, the originator sells its rights in the cashflow-generating asset(s) to a bankruptcy-remote special purpose vehicle company (SPV) in return for a lump-sum payment. The SPV funds the purchase of the assets by issuing the ABS debt to investors. The SPV then repays the ABS debt to the investors with the cashflows generated by the asset(s).

Securitisation has the following advantages:

• immediate cash;

• more cash available;

• higher rating/cheaper finance;

• broader class of investor; and

• improved debt/equity ratio - surplus cash is passed back to the originator as profit.

Underlying assets typical in ABS transactions are those which generate stable and predictable income streams (eg, real estate, mortgage portfolios and aircraft leases). However, in recent years the ABS asset class has widened and investors have shown increasing interest in intellectual property as an asset class for this purpose.

Basics of IP assets and how they can be securitised

The term ‘intellectual property’ refers to a set of rights conferred through statute or common law. These rights vest in the creators of original concepts, brands, products and inventions and, broadly speaking, allow the IP creator to prevent others from using the intellectual property outright or taking substantial parts of it. The main sets of IP rights that lend themselves to IP securitisation are patents, copyright and trademarks. It is useful to examine each of these rights to illustrate how they can generate cashflows.

Patents

A patent is a monopoly right that enables the proprietor to prevent others from using the technology developed by it without its license. A patent lasts for a fixed period (20 years). Therefore, by licensing third parties to use the underlying technology of the patent, the proprietor can generate regular cashflows in the form of royalty payments. Patents with several years of proven licensing revenues or patents relating to technologies that form part of industry standards will provide good opportunities for ABS investors....

Conclusion

IP-backed securitisations present unique challenges as compared to securitisations based on more established asset classes. However, past successes have shown that no challenge is insurmountable and, with increased experience in dealing with IP rights, the consequently greater familiarity with them and how best to structure deals on which they are based, the challenges should become easier to meet in future. Combined with the substantial value of IP assets on company balance sheets and the increased awareness of their true value, these developments suggest that the deal flow for IP-based securitisations is likely to become stronger in the coming years.

http://www.buildingipvalue.com/06Global/063_066.htm




Using the $260B figure of products sold annually, which infringe the jointly owned MMP Portfolio:


Nine years (Patents valid through 2015) multiplied by $260B = $2.34 Trillion.

A conservative 2% royalty of $2.34T = $46.8 Billion divided by 2 (50/50 Moore-TPL & PTSC) = $23.4 Billion per joint owner.

In the event the Moore-TPL / PTSC coadunation should broker an IP backed securitisation in regard to the MMP Portfolio of digitally fundamental Patents; IMO - with Court validation, the MMP Portfolio is worth (in the absolute ridiculously most conservative of estimates) no less than 5 Billion per joint owner.





--------------------------------------------------

AGORACOM Marketplace

 

wird mir echt schwindlig, wenn ich mir überlege, was mit PTSC passieren könnte....wenn es dazu kommt, werde ich dabei sein, dann kann ich mir es vielleicht sogar leisten, den Abenteurer zu einem "Berliner Kindl" (im doppelten Sinne) einzuladen :-)).  

 

für Dich reicht das natürlich dann auch noch *fg*.  

 

und schmeiss auch noch ne Runde. Oder besser noch, Burger beim Sausalitos. :-)  

Hört sich gut an, schließ ich mich gerne an.